Newsfeeds Archive - Page 687 of 19074

1 minute read

VBI Vaccines To Present New Interim Phase 2b Data From VBI-1901 In Recurrent Glioblastoma Patients In Poster Presentation At 2024 ASCO Annual Meeting

May 22, 8:04 AM

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the

VBIV

1 minute read

Vivek Ramaswamy Breathes New Life In Beaten Down BuzzFeed Stock: What’s Going On?

By Vandana Singh

May 22, 8:04 AM

BuzzFeed shares surged after Vivek Ramaswamy acquired a 7.7% stake for $3.2 million.

BZFD

1 minute read

These Analysts Slash Their Forecasts On AutoZone After Weak Sales

By Avi Kapoor

May 22, 8:03 AM

AutoZone, Inc (NYSE:AZO) reported worse-than-expected third-quarter sales results on Tuesday. The company reported third-quarter earnings per share of…

AZO

1 minute read

Crinetics Pharmaceuticals Announces ENDO 2024 Late-Breaking Abstracts; Were Released Earlier Than The Previously Announced Embargoed Date; More Fulsome Data Set Will Be Shared Within The Poster Presentations Scheduled To Be Presented On June 3, 2024

By Benzinga Newsdesk

May 22, 8:02 AM

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors,

CRNX

3 minute read

Analyst Ratings

A Closer Look at 8 Analyst Recommendations For Macy’s

By Benzinga Insights

May 22, 8:01 AM

Macy’s (NYSE:M) has been analyzed by 8 analysts in the last three months, revealing a diverse range of…

3 minute read

Analyst Ratings

Key Takeaways From AMETEK Analyst Ratings

By Benzinga Insights

May 22, 8:01 AM

Ratings for AMETEK (NYSE:AME) were provided by 4 analysts in the past three months, showcasing a mix of…

AME

4 minute read

Analyst Ratings

Expert Ratings For Tandem Diabetes Care

By Benzinga Insights

May 22, 8:00 AM

11 analysts have shared their evaluations of Tandem Diabetes Care (NASDAQ:TNDM) during the recent three months, expressing a…

TNDM

4 minute read

Analyst Ratings

Navigating 5 Analyst Ratings For Atlanticus Holdings

By Benzinga Insights

May 22, 8:00 AM

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Atlanticus Holdings…

ATLC

2 minute read

Why Is Retail Giant Target Stock Plunging Today?

By Shivani Kumaresan

May 22, 8:00 AM

Target shares fell as first-quarter FY24 adjusted EPS missed estimates. Despite a 3.1% year-on-year sales decline to $24.531 billion, exceeding expectations, comparable sales dropped 3.7%. Target forecasts FY24 adjusted EPS of $8.60 - $9.60 with a 0%-2% rise in comparable sales.

TGT